Literature DB >> 7630634

Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma.

P Trivedi1, Q J Zhang, F Chen, J Minarovits, M Ekman, P Biberfeld, G Klein, G Winberg.   

Abstract

In the Burkitt lymphoma line Oma-BL1, EBV positive and negative cells coexist. We demonstrate that EBV positive and negative subclones are identical with respect to chromosome markers and HLA type and that the same c-myc rearrangement occurs in all the subclones. This shows that the tumor cells are derived from the same patient and are of monoclonal origin. In the positive subclones, the EBV genome was stably maintained in the episomal form. The EBV negative subclones could be derived from previously uncloned tumor cells in early passage, but not from the EBV positive subclones.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630634

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.

Authors:  Francesco Boccellato; Eleni Anastasiadou; Paola Rosato; Bettina Kempkes; Luigi Frati; Alberto Faggioni; Pankaj Trivedi
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

2.  T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.

Authors:  Csaba Kiss; Jun Nishikawa; Kenzo Takada; Pankaj Trivedi; George Klein; Laszlo Szekely
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

3.  Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.

Authors:  P Rosato; E Anastasiadou; N Garg; D Lenze; F Boccellato; S Vincenti; M Severa; E M Coccia; R Bigi; M Cirone; E Ferretti; A F Campese; M Hummel; L Frati; C Presutti; A Faggioni; P Trivedi
Journal:  Leukemia       Date:  2012-04-19       Impact factor: 11.528

4.  Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas.

Authors:  Rossella Benedetti; Andrea Arena; Maria Anele Romeo; Maria Saveria Gilardini Montani; Roberta Gonnella; Roberta Santarelli; Pankaj Trivedi; Mara Cirone
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.